Decrease of Circulating Hematopoietic Progenitor Cells During Interleukin-2 Treatment is Associated with an Increase of Vascular Cell Adhesion Molecule-1, a Critical Molecule for Progenitor Cell Adhesion

References

• Brasel K, McKenna H J, Morrissey P J, Charrier K, Morris A E, Lee C C, William D E, Lyman S D. Hematologic effects of flt3 ligand in vivo in mice. Blood 1990; 88: 2004–2012
   Google Scholar
• Broxmeyer H E, Williams D E, Lu L, Cooper S, Anderson S L, Beyer G S, Hoffman R, Rubin B Y. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon-γ. J Immunol 1986; 136: 4487–4495
   PubMed Web of Science ®Google Scholar
• Broxmeyer H E, Lu L, Platzer E, Feit C, Juliano L, Rubin B Y. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), crythroid (BRU-E), and granulocyte-macrophage (CFU-GM) progenitor cells. J Immuno 1983; 131: 1300–1305
   PubMed Web of Science ®Google Scholar
• Dührsen U, Villeval J L, Boyd J, Kannourakis G, Morstyn G, Metcalf D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074–2081
   PubMed Web of Science ®Google Scholar
• Ettinghausen E S, Moore J G, White D E, Platanias L, Young N S, Rosenberg S A. Hematologic effects of immunotherapy with lymphokine-activated killer-cells and recombinant interleukin-2 in cancer patients. Blood 1987; 69: 1654–1660
   PubMed Web of Science ®Google Scholar
• Fibbe W E, Hamilton M S, Laterveer L L, Kibbelaar R E, Falkenburg J HF, Visser L WM, Willemze R. Sustained engraftment of mice transplanted with IL-I-primed blood-derived stem cells. J Immunol 1992; 148: 417–421
   PubMed Web of Science ®Google Scholar
• Geissler K, Kabrna E, Stengg S, Schwarzinger Kn I., Öbl P, Valent P, Eichinger S, Barge A, Lechner K. Recombinant human megakaryocyte growth and development factor increases levels of circulating haemopoietic progentior cells post chemotherapy in patients with acute myeloid leukaemia. Brit J Haematol 1998; 102: 535–543
   PubMed Web of Science ®Google Scholar
• Geissler K, Peschel C, Niederwieser D, Strobl H, Goldschmitt J, Öhler L, Bettelheim P, Kalhs P, Huber C, Lechner K, Höcker P, Kolbe K. Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3. Blood 1996; 87: 2732–2739
   PubMed Web of Science ®Google Scholar
• Geissler K, Stockenhuber F, Kabrna E, Hinterberger W, Balcke P, Lechner K. Recombinant human erythropoietin and hematopoietic progenitor cells in vivo (letter). Blood 1989; 73: 2229
   PubMed Web of Science ®Google Scholar
• Gianni A M, Bregni M, Stern A C, Bonadonna G, Siena S, Tarella C, Pileri A. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; 9: 580–585
   Google Scholar
• Gordon M, Dowding C R, Riley G P, Goldman J M, Greaves M F. Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myeloid leukemia. Nature 1987; 318: 342–344
   Web of Science ®Google Scholar
• Jacobsen K, Kravitz J, Kincade P W, Osmond D G. Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-I by reticular cells and sinusoidal endothelium in normal and γ-irradiated mice. Blood 1996; 87: 73–82
   PubMed Web of Science ®Google Scholar
• Laterveer L, Lindley I JD, Hamilton M S, Willemze R, Fibbe W E. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective: capacity and long term myelo-lymphoid repopulating ability. Blood 1995; 85: 2269–2275
   PubMed Web of Science ®Google Scholar
• Locker G J, Kapiotis S, Veitl M, Mader R M, Storiser B, Kofler J, Sieder A E, Rainer H, Steger G G, Mannhalter C, Wagner O F. Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders. Brit J Haematol 1999; 105: 912–919
   PubMed Web of Science ®Google Scholar
• Moskowitz C H, Stiff P, Gordon M S, McNiece I, Ho A D, Costa J J, Broun E R, Bayer R A, Wyres M, Hill J, Jelaca-Max-Well K, Nichols C R, Brown S, Nimer S D, Gabrilove J. Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in Non-Hodgkin's Lymphoma patients - results of a phase I/II trial. Blood 1997; 89: 3136–3147
   PubMed Web of Science ®Google Scholar
• Nakai K, Itoh C, Kawazoe K, Miura Y, Sotoyanagi H, Hotta K, Itoh T, Kamata J, Hiramori K. Concentration of soluble vascular cell adhesion molecule-I (VCAM-I) correlated with expression of VCAM-I mRNA in the human atherosclerotic aorta. Coron Artery Dis 1995; 6: 497–502
   PubMed Web of Science ®Google Scholar
• Oostendorp R AJ, Reisbaeh G, Spitzer E, Thalmeier Dienemann K. H., Mergenthaler H G., Dörmer P. VLA-4 and VCAM-I are the principal adhesion molecules involved in the interaction between blast colony-forming cells and bone marrow stomal cells. Blood 1995; 91: 275–284
   Google Scholar
• Papayannopoulou T, Craddock C, Nakamoto B, Priestley G V, Wolf N S. The VLA4/VCAM-I adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hematopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 1995; 92: 9647–9651
   PubMed Web of Science ®Google Scholar
• Peters W P, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C, Kurtzberg J. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993; 81: 1709–1719
   PubMed Web of Science ®Google Scholar
• Rasko J EJ, Basser R L, Boyd J, Mansfield R, O'Malley C J, Hussein S, Berndt M C, Clarke K, O'Brien J, Sheridan W P, Grigg A P, Begley C G. Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF. Brit J Haematol 1997; 97: 871–880
   PubMed Web of Science ®Google Scholar
• Ryan D H, Nuccie B L, Abboud C N, Winslow J M. Vascular cell adhesion molecule-I and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. Blood 1991; 88: 995–1004
   Google Scholar
• Schaafsma M R, Falkenburg J HF, Landegent J E, Duinkerken N, Osanto S, Ralph P, Kaushansky K, Wagemaker G, Damme J V, Willemze R, Fibbe W E. In vivo production of Interleukin-5, granulocyte-macrophage colony-stimulatin factor, macrophage colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients. Blood 1991; 78: 1981–1987
   PubMed Web of Science ®Google Scholar
• Sharar S R, Winn R K, Harlan J M. The adhesion cascade and anti-adhesion therapy: An overview. Springer Semin Immunopathol 1995; 16: 359–378
   PubMed Web of Science ®Google Scholar
• Sheridan W P, Begley C G, Juttner C A, Szer J, To L B, Maher D, McGrath K M, Morstyn G, Fox R M. Effect op peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotheryapy. Lancet 1992; 3: 640–644
   Web of Science ®Google Scholar
• Simmons P J, Masinovsky B, Longeneeker B M, Berenson R, Storb B T, Gallatin W M. Vascular cell adhesion molecule-I expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992; 80: 388–395
   PubMed Web of Science ®Google Scholar
• Skettino S, Phillips J, Lanier L, Nagler A, Greenberg P. Selective generation of erythroid burst-promoting activity by recombinant interleukin 2-stimulated human T lymphocytes and natural killer cells. Blood 1998; 71: 907–914
   Google Scholar
• Socinski M A, Elias A, Schnipper L, Cannistra S A, Antman K H, Griffin J D. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988; 5: 1194–1198
   Google Scholar
• Talmadge J F, Schneider M, Keller J, Ruscetti F, Longo D, Pennington R, Bowersox O, Tribble H. Myelostimulatory activity of recombinant human interleuking-2 in mice. Blood 1989; 73: 1458–1467
   PubMed Web of Science ®Google Scholar
• Tritarelli E, Rocca E, Testa U, Boccoli G, Camagna A, Calabresi F, Peschle C. Adoptive immunotherapy with high-dose interleukin-2: kinetics of circulating progenitors correlate with interleukin-6, granulocyte colony-stimulating factor level. Blood 1991; 77: 741–749
   PubMed Web of Science ®Google Scholar
• Velikova G, Banks R E, Gearing A, Hemingway I, Forbes M A, Preston S R, Hall N R, Jones M, Wyatt J, Miller K, Ward U, Al-Maskatti J, Singh S M, Finan P J, Ambrose N S, Primrose J N, Selby P J. Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer 1998; 77: 1857–1863
   PubMed Web of Science ®Google Scholar
• Williams D A, Rios M, Stephens C, Patel V P. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 1991; 352: 438–441
   PubMed Web of Science ®Google Scholar